Resiquimod, a topical drug for viral skin lesions and skin cancer.
Standard
Resiquimod, a topical drug for viral skin lesions and skin cancer. / Meyer, Thomas; Surber, Christian; French, Lars E; Stockfleth, Eggert.
In: EXPERT OPIN INV DRUG, Vol. 22, No. 1, 1, 2013, p. 149-159.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Resiquimod, a topical drug for viral skin lesions and skin cancer.
AU - Meyer, Thomas
AU - Surber, Christian
AU - French, Lars E
AU - Stockfleth, Eggert
PY - 2013
Y1 - 2013
N2 - Resiquimod is an immune response modifier which stimulates cells through a toll-like receptors (TLR) 7 and 8 dependent pathway resulting in activation of immune responses that are effective against viral and tumor lesions.
AB - Resiquimod is an immune response modifier which stimulates cells through a toll-like receptors (TLR) 7 and 8 dependent pathway resulting in activation of immune responses that are effective against viral and tumor lesions.
KW - Animals
KW - Humans
KW - Treatment Outcome
KW - Administration, Topical
KW - Skin Diseases/drug therapy
KW - Antiviral Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Antineoplastic Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Imidazoles/administration & dosage/adverse effects/pharmacokinetics
KW - Virus Diseases/drug therapy
KW - Animals
KW - Humans
KW - Treatment Outcome
KW - Administration, Topical
KW - Skin Diseases/drug therapy
KW - Antiviral Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Antineoplastic Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Imidazoles/administration & dosage/adverse effects/pharmacokinetics
KW - Virus Diseases/drug therapy
M3 - SCORING: Journal article
VL - 22
SP - 149
EP - 159
JO - EXPERT OPIN INV DRUG
JF - EXPERT OPIN INV DRUG
SN - 1354-3784
IS - 1
M1 - 1
ER -